Our goal in this paper is to study the effectiveness of the prophylactic standard dose of the anti-D immunoglobulin administration in pregnant women who are Rhesus D- negative. This is descriptive cross sectional hospital based study that carried out in Khartoum and Aldayat hospital, Sudan from April to July 2012. They are 50 respondents were recruited. Data is collected through questionnaire and 2 samples (serum and whole blood) are collected from each respondent. Also an antibody titration and Kleihauer Test is performed for each sample. They were 50 Rh-negative pregnant women who fulfill the eligibility criteria. Among these women, the result showed 14% positive for anti body titration and 86% negative in women who receive standard anti ...
BACKGROUND/AIMS: Prophylactic anti-D given during pregnancy can be detected in current indirect anti...
Objective: The objective of this study was to audit the use of anti-D immunoglobulin (anti-D) agains...
positive fetuses for routine antenatal anti-D prophylaxis (RAADP). positive fetuses. Main outcome m...
Our goal in this paper is to study the effectiveness of the prophylactic standard dose of the anti-D...
BACKGROUND:During pregnancy, a Rhesus negative (Rh-negative) woman may develop antibodies when her f...
To estimate the effectiveness of routine antenatal anti-D prophylaxis for preventing sensitisation i...
Objective: The main purpose of this study was the occurrence of the negative Rhesus factor strength ...
BACKGROUND: To estimate the effectiveness of routine antenatal anti-D prophylaxis for preventing sen...
Objective To assess the pharmacokinetics of anti-D IgG in pregnant Rhesus D-negative women after int...
Background. Despite the introduction of anti-D prophylaxis into clinical practice, RhD alloimmunizat...
The discovery, introduction and utilisation of Rh D immunoglobulin (anti-D) for prophylaxis against ...
BACKGROUND:Several anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the...
BackgroundThe development of Rh immunisation and its prophylactic use since the 1970s has meant that...
Objective: To estimate the incidence of RhD immunisation after implementation of first trimester non...
Haemolytic disease of the fetus/newborn secondary to clinically significant non-Rhesus-D antibodies ...
BACKGROUND/AIMS: Prophylactic anti-D given during pregnancy can be detected in current indirect anti...
Objective: The objective of this study was to audit the use of anti-D immunoglobulin (anti-D) agains...
positive fetuses for routine antenatal anti-D prophylaxis (RAADP). positive fetuses. Main outcome m...
Our goal in this paper is to study the effectiveness of the prophylactic standard dose of the anti-D...
BACKGROUND:During pregnancy, a Rhesus negative (Rh-negative) woman may develop antibodies when her f...
To estimate the effectiveness of routine antenatal anti-D prophylaxis for preventing sensitisation i...
Objective: The main purpose of this study was the occurrence of the negative Rhesus factor strength ...
BACKGROUND: To estimate the effectiveness of routine antenatal anti-D prophylaxis for preventing sen...
Objective To assess the pharmacokinetics of anti-D IgG in pregnant Rhesus D-negative women after int...
Background. Despite the introduction of anti-D prophylaxis into clinical practice, RhD alloimmunizat...
The discovery, introduction and utilisation of Rh D immunoglobulin (anti-D) for prophylaxis against ...
BACKGROUND:Several anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the...
BackgroundThe development of Rh immunisation and its prophylactic use since the 1970s has meant that...
Objective: To estimate the incidence of RhD immunisation after implementation of first trimester non...
Haemolytic disease of the fetus/newborn secondary to clinically significant non-Rhesus-D antibodies ...
BACKGROUND/AIMS: Prophylactic anti-D given during pregnancy can be detected in current indirect anti...
Objective: The objective of this study was to audit the use of anti-D immunoglobulin (anti-D) agains...
positive fetuses for routine antenatal anti-D prophylaxis (RAADP). positive fetuses. Main outcome m...